22 These diseases will manifest with acute liver disease, hypoglycemia, high creatine kinase, and cardiomyopathy, associated to hyperammonemia
doi: 10.1093/AJCN/76.3.560 161 LachanceHWetzelSKumarKWaldmannH
Future of GLP-1 medications Pharma companies are developing new formulations, combinations and delivery methods to enhance efficacy and patient convenience
Xia B, Yang M, Nguyen LH, He Q, Zhen J, Yu Y, et al
Why are we so insistent on Bacteriostatic Water
The correlation between the anti-inflammatory properties of GLP-1RA and clinical outcomes need more research